 |
|
| IN CLINICAL PRACTICE: CARDIOVASCULAR RISK MANAGEMENT
| |
| | |
|
|
To order this title, and for more information, click here
Edited By
W. Stephen Waring, BMedSci, MB, FRCP(UK), PhD, Consultant Physician, Royal Infirmary of Edinburgh, and Honorary Senior Lecturer, The University of Edinburgh, UK
Included in series
Churchill's In Clinical Practice,
Description
For many years, individual cardiovascular risk factors have been dealt with in isolation, often by specialists with an interest in one
particular risk factor, for example hypertension or hypercholesterolaemia. There has recently been a move to emphasise the importance
of reducing global cardiovascular risk, which requires clinicians to address any one of a number of different risk factors. The interplay
between these various factors is important in our understanding of development of cardiovascular disease and, similarly, the synergistic
effects of targeting different risk factors is important in risk reduction. This text provides a comprehensive and up-to-date review
of modern cardiovascular risk management. It belongs to the ?In Clinical Practice' series, which incorporate multiple illustrations using
novel and effective formats. Data are frequently presented as bullet point lists or tables so that the key information is clearly available.
The emphasis is on overall cardiovascular risk reduction throughout, with integration of lifestyle and pharmacological interventions.
Audience
Junior hospital doctors on cardiac and medical rotations and primary care physicians.
Contents
INTRODUCTION
Epidemiology
Morbidity
Financial impact
CARDIOVASCULAR DISEASE PREVENTION
Risk factors for cardiovascular
disease
Overall cardiovascular risk prediction
Summary
LIFESTYLE
Impact of lifestyle on cardiovascular risk factors
Dietary
supplements
Implementing lifestyle changes
Conclusion
SMOKING CESSATION
Induction of a hypercoagulable state
Reduction
tissue oxygen delivery
Haemodynamic effects
Endothelial dysfunction
Benefits of smoking cessation
Nicotine replacement therapy
Bupropion
Combined nicotine replacement therapy and bupropion
OBESITY
DIABETES MELLITUS
Epidemiology
Financial burden of diabetes
Diabetes
as a cardiovascular risk factor
Early detection of diabetes by screening
Assessing cardiovascular risk and prognosis
Microalbuminuria
Diabetic
nephropathy
Need for specialist intervention
Summary
DYSLIPIDAEMIA
Dyslipidaemia and cardiovascular risk
Prevalence of
dyslipidaemia
Definition and diagnosis of dyslipidaemia
Reducing the risk
Conclusions
HYPERTENSION
Definition of hypertension
Prevalence
of hypertension
Measurement of blood pressure
Making a clinical diagnosis of hypertension
Pathogenesis of hypertension
Initial
assessment in hypertension
Treatment of hypertension
Postural hypotension
Need for specialist intervention
Importance of
hypertension as a cardiovascular risk factor in diabetes
Hypertension in patients with renal disease
Hypertension in obese patients
Conclusions
ANTIPLATELET
THERAPY
Dual antiplatelet therapy
PATIENT ISSUES AND COMPLIANCE
CONCLUSION
| Bibliographic details |
Paperback, 160 pages, publication date: NOV-2006
ISBN-13: 978-0-443-10174-8
ISBN-10: 0-443-10174-4
Imprint: CHURCHILL LIVINGSTONE
|
999/999
Last update: 30 Oct 2009
|
|
| |
| | |
|
|
| |
Home | Elsevier Sites | Privacy Policy | Terms and Conditions | Feedback | Site Map | A Reed Elsevier Company